A detailed history of Kistler Tiffany Companies, LLC transactions in Invitae Corp stock. As of the latest transaction made, Kistler Tiffany Companies, LLC holds 1,350 shares of NVTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,350
Previous 1,350 -0.0%
Holding current value
$0
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$1.2 - $2.73 $32 - $73
-27 Reduced 1.96%
1,350 $1,000
Q2 2021

Aug 04, 2021

BUY
$26.09 - $40.4 $182 - $282
7 Added 0.51%
1,377 $46,000
Q1 2021

May 07, 2021

BUY
$33.06 - $56.93 $11,571 - $19,925
350 Added 34.31%
1,370 $52,000
Q2 2020

Jul 20, 2020

BUY
$11.71 - $30.29 $11,944 - $30,895
1,020 New
1,020 $31,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Kistler Tiffany Companies, LLC Portfolio

Follow Kistler Tiffany Companies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kistler Tiffany Companies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kistler Tiffany Companies, LLC with notifications on news.